Istituto ortopedico Gaetano Pini
Milan, Italy
NCT Number: NCT02589288
The aim of this prospective, randomized , blinded study is to compare two different infusion techniques (continuous VS intermittent automatic bolus) to assess the effects of postoperative analgesia after Day-Case anterior cruciate ligament (ACL) reconstruction.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Milan, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Postoperative continuous infusion of Ropivacaine 0,2% at 6 ml/h and 4 ml PCA bolus, lockout 20 minutes via electronic infusion pump (Micrel device, Greece).
Other names: naropine 0.2%
Postoperative Automatic Intermittent Bolus of 6 ml Ropivacaine 0,2% every hour and 4 ml PCA bolus, lockout 20 minutes via electronic infusion pump (Micrel device, Greece).
Time frame: 72h postoperative
Evaluation of numeric rating score (NRS) in patient with automatic intermittent bolus of Ropivacaine 0,2% instead of classic continuous perfusion
Time frame: 72h postoperative
"up and go" test: time need to get up from a chair, walk for 3 meters, and come back to seat down on the chair
Time frame: 72h postoperative
Opioids consumption will be recorded throughout 72 postoperative hours
Time frame: 72h postoperative
Evaluation of local anesthesia consumption every 6h in first 72 postoperative hours.
Time frame: 72h postoperative
time need to walk 10 meters
ASST Gaetano Pini-CTO
Other
Adductor Canal Block: Continuous Infusion Versus Automatic Intermittent Bolus For Postoperative Analgesia After Day-Case Anterior Cruciate Ligament Reconstruction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02933008
Anterior Cruciate Ligament Injuries, Injury of Anterior Cruciate Ligament
Flowery Branch, Georgia, United States
View Trial DetailsNCT01937403
Anterior Cruciate Ligament Injuries, Injury of Anterior Cruciate Ligament
Greenville, South Carolina, United States
View Trial DetailsNCT02937064
Anterior Cruciate Ligament Injuries, Arthritis
Oulu, Finland
View Trial DetailsNCT02422771
Anterior Cruciate Ligament Injuries, Injury of Anterior Cruciate Ligament
Winnipeg, Manitoba, Canada
View Trial Details